The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Understanding LRRK2 Biology, 2009Characterization of LRRK2 Cellular and Signaling Pathways
Objective/Rationale:
Mutations in LRRK2 are thus far the most common known cause of late-onset Parkinson’s disease (PD). The most prevalent LRRK2 mutation G2019S has been shown to stimulate LRRK2... -
Understanding LRRK2 Biology, 2009Elucidating the Function and Downstream Targets of LRRK2
Objective/Rationale:
One of the most exciting recent advances in PD research is that mutations within the gene coding for a protein of unknown function, LRRK2, predispose people to PD. Since a number... -
Understanding LRRK2 Biology, 2009LRRK2 in Neuronal Architecture
Objective/Rationale:
Past observations in LRRK2 pre-clinical models have lead us to develop a unified hypothesis for LRRK2’s role in signaling/scaffolding and neuronal membrane dynamics. By utilizing... -
Understanding LRRK2 Biology, 2009Investigating signaling pathway dysfunction linked to LRRK2
Objective/Rationale:
Mutations in the gene LRRK2 are responsible for tens of thousands of cases of Parkinson’s disease, and are the most common genetic cause of this disease. At present we don’t... -
Understanding LRRK2 Biology, 2009Biochemical Characterization of Full Length Human Recombinant LRRK1 and LRRK2
Objective/Rationale:
Mutations in one gene, LRRK2, are a common cause of Parkinson’s disease. However, the protein product of this gene is large and complex and, to date, no one has been able to make... -
Understanding LRRK2 Biology, 2009LRRK2 Mediated Pathogenic Pathways in Dopaminergic Axonal Degeneration and Synaptic Transmission
Objective/Rationale:
Mutations in the LRRK2 gene occur with high frequency in familial and sporadic Parkinson disease. We have established a R1441G-LRRK2 transgenic pre-clinical model that...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.